CN101829320B - 一种胶原蛋白凝胶及其制备方法 - Google Patents
一种胶原蛋白凝胶及其制备方法 Download PDFInfo
- Publication number
- CN101829320B CN101829320B CN2010101787938A CN201010178793A CN101829320B CN 101829320 B CN101829320 B CN 101829320B CN 2010101787938 A CN2010101787938 A CN 2010101787938A CN 201010178793 A CN201010178793 A CN 201010178793A CN 101829320 B CN101829320 B CN 101829320B
- Authority
- CN
- China
- Prior art keywords
- collagen
- gel
- collagen gel
- substrate
- antibacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000512 collagen gel Substances 0.000 title claims abstract description 66
- 238000002360 preparation method Methods 0.000 title abstract description 5
- 102000008186 Collagen Human genes 0.000 claims abstract description 36
- 108010035532 Collagen Proteins 0.000 claims abstract description 36
- 239000000758 substrate Substances 0.000 claims abstract description 21
- 239000002270 dispersing agent Substances 0.000 claims abstract description 20
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 16
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical group CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 33
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 24
- 229910052709 silver Inorganic materials 0.000 claims description 15
- 239000004332 silver Substances 0.000 claims description 15
- 230000002421 anti-septic effect Effects 0.000 claims description 13
- -1 hydroxypropyl Chemical group 0.000 claims description 12
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 12
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 12
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 12
- 229960003415 propylparaben Drugs 0.000 claims description 12
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 11
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 11
- 239000012153 distilled water Substances 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 7
- 239000010408 film Substances 0.000 claims description 4
- 206010052428 Wound Diseases 0.000 abstract description 42
- 208000027418 Wounds and injury Diseases 0.000 abstract description 39
- 230000000694 effects Effects 0.000 abstract description 17
- 238000000034 method Methods 0.000 abstract description 16
- 229920001661 Chitosan Polymers 0.000 abstract description 15
- 229920001436 collagen Polymers 0.000 abstract description 14
- 230000029663 wound healing Effects 0.000 abstract description 12
- 239000003242 anti bacterial agent Substances 0.000 abstract 4
- 239000003755 preservative agent Substances 0.000 abstract 3
- 230000002335 preservative effect Effects 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 239000006185 dispersion Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 230000003810 hyperpigmentation Effects 0.000 abstract 1
- 208000000069 hyperpigmentation Diseases 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 11
- 230000002980 postoperative effect Effects 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 210000000589 cicatrix Anatomy 0.000 description 9
- 230000008439 repair process Effects 0.000 description 9
- 208000025865 Ulcer Diseases 0.000 description 8
- 230000003115 biocidal effect Effects 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 231100000397 ulcer Toxicity 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 7
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 102000012422 Collagen Type I Human genes 0.000 description 6
- 108010022452 Collagen Type I Proteins 0.000 description 6
- 230000019612 pigmentation Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 206010063560 Excessive granulation tissue Diseases 0.000 description 5
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 5
- 230000001408 fungistatic effect Effects 0.000 description 5
- 210000001126 granulation tissue Anatomy 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 208000019802 Sexually transmitted disease Diseases 0.000 description 4
- 238000004945 emulsification Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010059866 Drug resistance Diseases 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 229920003086 cellulose ether Polymers 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 108010025899 gelatin film Proteins 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- 230000001524 infective effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000037311 normal skin Effects 0.000 description 3
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 206010040882 skin lesion Diseases 0.000 description 3
- 231100000444 skin lesion Toxicity 0.000 description 3
- 230000008467 tissue growth Effects 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 2
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 2
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000002316 cosmetic surgery Methods 0.000 description 2
- 230000006196 deacetylation Effects 0.000 description 2
- 238000003381 deacetylation reaction Methods 0.000 description 2
- 238000001804 debridement Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 239000005022 packaging material Substances 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical group OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical group CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 208000001387 Causalgia Diseases 0.000 description 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000010398 acute inflammatory response Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000007838 tissue remodeling Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101787938A CN101829320B (zh) | 2010-05-20 | 2010-05-20 | 一种胶原蛋白凝胶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101787938A CN101829320B (zh) | 2010-05-20 | 2010-05-20 | 一种胶原蛋白凝胶及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101829320A CN101829320A (zh) | 2010-09-15 |
CN101829320B true CN101829320B (zh) | 2012-05-23 |
Family
ID=42713640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101787938A Active CN101829320B (zh) | 2010-05-20 | 2010-05-20 | 一种胶原蛋白凝胶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101829320B (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102936390B (zh) * | 2012-11-06 | 2014-09-17 | 南京理工大学 | 胶原蛋白-g-聚合物/Ag多孔纳米抗菌薄膜材料及制备方法 |
CN104479368B (zh) * | 2014-12-10 | 2017-03-29 | 国家纳米科学中心 | 一种纳米纤维素增强的全生物降解薄膜及其制备方法 |
CN104474535A (zh) * | 2014-12-10 | 2015-04-01 | 成都新际生物活性胶原开发有限公司 | 一种治疗糖尿病足的水溶性凝胶 |
CN105218662B (zh) * | 2015-09-18 | 2018-08-21 | 四川大学 | 一种基于磁性可回收纳米抗菌剂的胶原净化及防腐方法 |
CN105168936A (zh) * | 2015-10-13 | 2015-12-23 | 鞠进英 | 一种纳米愈伤护理凝胶及其制备方法 |
CN105327389B (zh) * | 2015-11-23 | 2018-11-27 | 四川大学 | 基于胶原聚集体的絮状抗菌止血材料及其制备方法 |
CN106563156A (zh) * | 2016-10-18 | 2017-04-19 | 江南大学 | 一种具有成膜性的凝胶创面敷料 |
CN106692953A (zh) * | 2017-02-03 | 2017-05-24 | 上海麦琳生物医学工程科技有限公司 | 一种蓝鲨鱼皮胶原蛋白复合凝胶制剂及其制备方法与应用 |
CN117100691A (zh) * | 2017-04-07 | 2023-11-24 | 赛可勒生物医学避孕法有限公司 | 粘液屏障性能的增强 |
CN107261207B (zh) * | 2017-06-28 | 2020-11-24 | 广州益诚生物科技有限公司 | 一种胶原蛋白凝胶及其制备方法 |
CN107737050A (zh) * | 2017-11-29 | 2018-02-27 | 桂林华诺威生物科技有限公司 | 胶原蛋白光子冷凝胶 |
CN109331208A (zh) * | 2018-11-02 | 2019-02-15 | 江门市和馨香精技术有限公司 | 一种具有膏霜质感的空气净化凝胶及其制备方法 |
CN110898038A (zh) * | 2019-12-13 | 2020-03-24 | 厦门肽王基因科技有限公司 | 一种鲨鱼肽凝胶涂膜剂及其制备方法 |
CN110787288A (zh) * | 2019-12-25 | 2020-02-14 | 郑州康金瑞健康产业有限公司 | 医用胶原蛋白口腔溃疡防护凝胶及其制备方法 |
TWI754279B (zh) * | 2020-05-13 | 2022-02-01 | 國立屏東科技大學 | 用以產生人工痂皮的傷口修復套組 |
CN113354839B (zh) * | 2020-08-26 | 2022-08-23 | 胶原蛋白(武汉)生物科技有限公司 | 一种胶原蛋白-银纳米粒子复合凝胶、制备方法及应用 |
CN113786513A (zh) * | 2021-10-25 | 2021-12-14 | 西安德诺海思医疗科技有限公司 | 一种长期稳定的重组胶原蛋白敷料及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1927393A (zh) * | 2005-09-08 | 2007-03-14 | 佟刚 | 复合胶原蛋白凝胶 |
-
2010
- 2010-05-20 CN CN2010101787938A patent/CN101829320B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1927393A (zh) * | 2005-09-08 | 2007-03-14 | 佟刚 | 复合胶原蛋白凝胶 |
Also Published As
Publication number | Publication date |
---|---|
CN101829320A (zh) | 2010-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101829320B (zh) | 一种胶原蛋白凝胶及其制备方法 | |
Moraes et al. | Bacterial cellulose/collagen hydrogel for wound healing | |
Kong et al. | Biomimetic hydrogel for rapid and scar-free healing of skin wounds inspired by the healing process of oral mucosa | |
CN101371925B (zh) | 一种纳米银-细胞生长因子缓释物及其制备方法与用途 | |
CN100471528C (zh) | 具有促进伤口愈合、抗菌功能的液体伤口敷料 | |
CN106075556A (zh) | 含有促进伤口愈合药物的医用复合壳聚糖凝胶 | |
RU2422133C1 (ru) | Гидрофильный гель, способ его получения (варианты), раневое покрытие и перевязочное средство на его основе | |
CN107185031B (zh) | 一种具有生物活性的医用敷料及其制备方法 | |
CN107617121B (zh) | 一种皮肤创面生物诱导活性敷料及其制备方法和应用 | |
EP2815754A1 (en) | Compositions for disrupting and inhibiting reconstitution of wound biofilm | |
CN103025386A (zh) | 用于治疗微生物感染的罗望子种子多糖 | |
CN111068103B (zh) | 一种手术伤口用长效抑菌凝胶敷料及其制备方法 | |
CN111481498A (zh) | 一种调节女性***微生态平衡的抑菌凝胶及其制备方法 | |
CN106063798B (zh) | 一种口腔溃疡贴膜及其制备方法 | |
Khan et al. | Aloe vera and ofloxacin incorporated chitosan hydrogels show antibacterial activity, stimulate angiogenesis and accelerate wound healing in full thickness rat model | |
Lee et al. | Evaluation of Melia azedarach extract-loaded poly (vinyl alcohol)/pectin hydrogel for burn wound healing | |
CN105169464B (zh) | 一种天然蜂蜜伤口敷料及其制备方法与应用 | |
Issaka | State-of-the-art of synthesized exosomes and NPs-based biomimetic nanoparticles for wound rehabilitation: a review | |
CN107595819B (zh) | 一种纳米金刚石改性液体创可贴及其制备方法 | |
Imran et al. | Tualang honey hydrogel in the treatment of split-skin graft donor sites | |
CN111905058A (zh) | 一种用于皮肤黏膜护理和伤口修复的药物组合物及其制备方法 | |
Liu et al. | Study on scar repair and wound nursing of chitosan-based composite electrospun nanofibers in first aid of burn | |
CN106474137B (zh) | 一种含有叶绿素的口腔溃疡贴膜及其制备方法 | |
CN110869062A (zh) | 用于在皮肤损伤的处理中局部应用的薄膜及其获得和应用方法 | |
CN105055713A (zh) | 一种预防或治疗褥疮的药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGZHOU TRAUER BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: TONG GANG Effective date: 20120412 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20120412 Address after: 510663, Guangdong, Guangzhou Science City, Xiangshan Road, No. 17, excellent science and Technology Park, block A, four Patentee after: Guangzhou Trauer Biotechnology Co., Ltd. Address before: 510663, No. four, No. 17, block A, excellent industrial park, Xiangshan Road, Luogang Science Development Zone, Guangzhou, Guangdong Patentee before: Tong Gang |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 510663, Guangdong, Guangzhou Science City, Xiangshan Road, No. 17, excellent science and Technology Park, block A, four Patentee after: Guangzhou Trauer Biotechnology Co., Ltd. Address before: 510663, Guangdong, Guangzhou Science City, Xiangshan Road, No. 17, excellent science and Technology Park, block A, four Patentee before: Guangzhou Trauer Biotechnology Co., Ltd. |